Company Filing History:
Years Active: 2007-2012
Title: George H. Snedeker: Innovator in Targeted Drug Delivery Systems
Introduction
George H. Snedeker, an accomplished inventor based in Wooster, Ohio, is recognized for his contributions to the field of medical technology. With a total of two patents to his name, he has made significant strides in enhancing drug delivery systems, particularly for therapeutic and diagnostic applications in warm-blooded hosts. His innovative work is instrumental in advancing the capabilities of targeted treatments.
Latest Patents
Snedeker's latest patent focuses on a targeted liposomal drug delivery system. This invention involves a metal targeting complex that associates with a charged liposomal structure. The complex significantly enhances the targetability of the liposomal construct, allowing it to reach specific receptor sites in warm-blooded hosts. This advancement holds promise for improving therapeutic outcomes and diagnostic accuracy.
Career Highlights
George H. Snedeker is currently associated with SDG LLC, where he applies his expertise in the design and development of innovative drug delivery systems. His work emphasizes the importance of precision in medical treatments, paving the way for more effective therapies.
Collaborations
In his innovative journey, Snedeker collaborates with talented colleagues, including John R. Lau and W. Blair Geho. These partnerships foster a dynamic environment for creativity and advancement in the field of drug delivery technologies.
Conclusion
George H. Snedeker stands out as a notable inventor whose work in targeted drug delivery systems exemplifies the intersection of innovation and practicality in medicine. With his patents, he contributes significantly to the evolution of therapeutic practices, demonstrating the impact of inventors in advancing healthcare solutions.